HYPERION DEFI, INC. Proceeds from Issuance of Private Placement
HYPERION DEFI, INC. (HYPD) reported Proceeds from Issuance of Private Placement of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2022-03-30
- HYPERION DEFI, INC. proceeds from issuance of private placement for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- HYPERION DEFI, INC. proceeds from issuance of private placement for the quarter ending 2020-12-31 was $0.00.
- HYPERION DEFI, INC. proceeds from issuance of private placement for the quarter ending 2020-09-30 was $0.00.
- HYPERION DEFI, INC. proceeds from issuance of private placement for the quarter ending 2020-06-30 was $0.00.
- HYPERION DEFI, INC. proceeds from issuance of private placement for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- HYPERION DEFI, INC. proceeds from issuance of private placement for fiscal 2020 was $5.57M.
- HYPERION DEFI, INC. proceeds from issuance of private placement for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $5.57M 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $5.57M 10-Q · filed 2021-11-12 | $5.57M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.57M 10-Q · filed 2021-08-12 | $5.57M derived: sum of 3 quarters · filed 2021-08-12 | $5.57M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $5.57M 10-Q · filed 2021-05-14 | $5.57M derived: sum of 2 quarters · filed 2021-05-14 | $5.57M derived: sum of 3 quarters · filed 2021-05-14 | $5.57M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |